Clinical Trials
16 trialsNCT05702229 2026-05-14
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Phase 2 Recruiting
NCT07448142 2026-05-07
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT07007182 2026-05-01
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT07562503 2026-05-01
CLEAR-03
Fudan University
Phase 2 Recruiting
NCT06475352 2026-04-23
FUDOSE
UNICANCER
Phase 2 Recruiting
NCT06850103 2026-03-25
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT07468630 2026-03-12
TRIUNITE-08
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Recruiting
NCT07108127 2025-08-06
NePHera
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06808412 2025-02-05
To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
Xijing Hospital of Digestive Diseases
Phase 2 Recruiting
NCT06242418 2024-12-12
REVISE
West China Hospital
Phase 2 Recruiting
NCT06506292 2024-07-17
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06196697 2024-06-27
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Harbin Medical University
Phase 2 Recruiting
NCT03714490 2024-05-29
SUNRISE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT06023758 2024-05-10
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Peking University
Phase 2 Recruiting
NCT05228431 2024-04-22
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT05494060 2023-11-07
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting